To explore the role of SHP-1 in the pathogenesis of IPF, SC-43, a small molecule SHP-1 agonist [26, 27] was administrated in bleomycin-induced pulmonary fibrosis mice, which are a broadly used pre-clinical model for IPF research. Here, PTPN6 is linked to idiopathic pulmonary fibrosis.